Dr Tina Wang | Chief Operating Officer
Lion TCR | Singapore

Tina led a distinguished career in oncology spanning over 20 years, demonstrating her strong leadership in the biopharmaceutical industry, clinical practice and
translational medical research. She has an extensive background in immunotherapeutic drug and assay development as well as commercialization of oncological products.

She successfully led the global clinical development of both autologous and allogenic CD30.CAR-T cells therapy for lymphoma patients at Tessa Therapeutics. At Roche Diagnostics Asia Pacific, she led the Asia Pacific Oncology Team for the successful pre-launch and launch of VENTANA PD-L1 assays (SP142, SP263). Tina published around 20 original papers in peer reviewed journals, identifying biomarkers for solid tumours across gastric, colon and breast cancers.